Related Experiment Video
Updated: Apr 18, 2026
21:08
Engineering Cell-permeable Protein
Published on: December 28, 2009
15.2K
Engineering therapeutic proteins for cell entry: the natural approach
Sandrine Guillard1, Ralph R Minter1, Ronald H Jackson1
1Department of Antibody Discovery and Protein Engineering, MedImmune, Milstein Building, Granta Park, Cambridge CB21 6GH, UK.
Trends in Biotechnology
|January 18, 2015
Summary
New protein delivery systems mimic natural mechanisms to target intracellular diseases. This breakthrough allows potent protein drugs to reach previously inaccessible intracellular targets, offering new therapeutic options.
Area of Science:
- Biotechnology and Pharmaceutical Sciences
- Cellular and Molecular Biology
- Drug Delivery Systems
Background:
- Protein-based therapies are limited to extracellular targets due to cell entry challenges.
- Intracellular targets are primarily addressed by small molecules, limiting therapeutic options.
- Developing effective intracellular protein delivery is crucial for expanding therapeutic potential.
Purpose of the Study:
- To review novel strategies for delivering therapeutic proteins into specific intracellular compartments.
- To highlight the adaptation of natural protein entry mechanisms for drug delivery.
- To explore the potential of protein-based therapies for previously inaccessible intracellular targets.
Main Methods:
- Review of existing literature on natural protein entry mechanisms (e.g., toxins).
- Analysis of innovative approaches designed to mimic these natural delivery systems.
- Evaluation of early clinical data demonstrating the efficacy of new delivery systems.
Main Results:
- Development of new systems that successfully facilitate protein entry into cells.
- Demonstration of clinical efficacy for protein therapies utilizing these novel delivery methods.
- Validation of natural mechanisms as a basis for effective intracellular protein delivery.
Conclusions:
- Mimicking natural protein entry mechanisms offers a viable strategy for intracellular drug delivery.
- These advancements enable potent and specific protein therapeutics to target intracellular diseases.
- The development of these systems broadens the scope of treatable conditions with protein-based drugs.
Related Concept Videos
01:27Transducer Mechanism: Enzyme-Linked Receptors
5.1K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
5.1K
01:45Tail-anchoring of Proteins in the ER Membrane
4.1K
Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...
4.1K